microdosing glp-1 for maintenance GLP-1s: What You Should Know Microdosing GLP-1: What to Know

Commissioner Makary stated: "Compounded drugs can be important for overcoming shortages or meeting unique patient needs, but compounders should not try to compound drugs in a way that circumvents FDA's approval process." While these targeted injectables, not herbal patches, the regulatory direction is clear

Given that GLP-1 RAs may offer therapeutic options for addressing psychiatric symptoms, it is crucial to evaluate the potential risk of increased suicide rates associated with their use

It is assumed that the favorable cardiovascular profile of GLP-1RAs can expand their therapeutic use for the treatment of cardiovascular diseases, even in people without diabetes [65]

Access may be subject to limitations based on institutional regulations and data protection policies